News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
265 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Policy
MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State
MDxHealth SA today announces that the New York State Department of Health has approved its SelectMDx test for Prostate Cancer.
November 28, 2018
·
4 min read
Policy
MorphoSys Announces Approval of Tremfya(R) (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis
MorphoSys AG announced today that its licensee’s affiliate, Janssen Pharmaceutical K.K. (Janssen) reported that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Tremfya(R) (guselkumab) for the treatment of patients with palmoplantar pustulosis who are not responding or are refractory to existing treatments.
November 28, 2018
·
6 min read
Drug Development
ASIT biotech has installed and qualified a pilot unit to produce clinical batches for the Phase I/II studies in house dust mite and peanut allergies expected to start in H2 2019
The active pharmaceutical ingredients (API) will be produced according to GMP requirements in a clean room rented from Accessia Pharma, a provider of high-quality pharmaceutical infrastructures
November 28, 2018
·
3 min read
Business
Families aid discovery of a sensory-processing gene in children with autism
Next step: Developing therapies to restore the gene product
November 28, 2018
·
6 min read
Job Trends
Treating a Rare Genetic Disorder That Causes Colon Cancer in Children
UH Pharmaceutical Scientist Eyeing New Drug that Recycles Through the Colon
November 28, 2018
·
3 min read
Drug Development
NOXXON TO LAUNCH NOX-A12 WITH RADIOTHERAPY CLINICAL TRIAL IN PATIENTS WITH BRAIN CANCER
New therapeutic combination is expected to be generally applicable to many solid tumors with high unmet medical need
November 28, 2018
·
5 min read
Business
ADSSSA holds influenza vaccination campaign in collaboration with Abu Dhabi Health Services Company (SEHA)
Abu Dhabi Smart Solutions and Services Authority, in collaboration with the Abu Dhabi Health Services Company (SEHA), organized a seasonal influenza vaccination campaign for its employees as a preventive measure to contain the spread of influenza virus at this time of the year.
November 28, 2018
·
1 min read
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as one of the commonly used maintenance medications in COPD (Chronic Obstructive Pulmonary Disease).
November 28, 2018
·
2 min read
Business
CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments
CBT’s c-Met inhibitor and anti-PD1 antibody to be evaluated in combination with Bossan’s EGFR inhibitor
November 28, 2018
·
4 min read
Business
Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children’s Hospital Medical Center
Aruvant’s pipeline anchored by RVT-1801, an investigational gene therapy for sickle cell disease and β-thalassemia
November 28, 2018
·
5 min read
Previous
4 of 27
Next